Short summary

Gliomas are brain tumors with diffuse growth, making surgical removal challenging. In a project with 48 patients, we used MALDI-MSI and machine learning to distinguish tumor from healthy and necrotic tissue at high resolution. As part of a new project, we now aim to include blood samples from glioma patients to explore lipid biomarkers as potential tools for monitoring tumor burden. The project and biobank are approved by the ethics committee

Description of the cohort

Patients with all intracranial tumors from department of neurosurgery, OUH.

Data and biological material

Blood and resected tissue samples

Collaborating researchers and departments

department of biochemistry and molecular biology university of southern denmark

• Ole Nørregaard Jensen